Use of recombinant human thyroid stimulating hormone (rhTSH) in therapy of differentiated thyroid carcinoma (DTC) with Iodine-131(I-131), in patients (pts) already treated after T4 withdrawal.

被引：0
|
作者：
Ferreira, TC [1 ]
Sevilla, A [1 ]
Garrao, A [1 ]
Henriques, M [1 ]
Limbert, E [1 ]
Vieira, MR [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S467 / S467
页数：1
相关论文
共 50 条
  • [31] Serum thyroglobulin concentrations and 131I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone
    David, A
    Blotta, A
    Bondanelli, M
    Rossi, R
    Roti, E
    Braverman, LE
    Busutti, L
    Uberti, ECD
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (10) : 1470 - 1475
  • [32] Recurrence-free survival and prognostic factors after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Iizuka, Y.
    Katagiri, T.
    Ogura, K.
    Inoue, M.
    Nakamura, K.
    Mizowaki, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S364 - S364
  • [33] Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal
    Cherk, Martin H.
    Francis, Peter
    Topliss, Duncan J.
    Bailey, Michael
    Kalff, Victor
    CLINICAL ENDOCRINOLOGY, 2012, 76 (05) : 734 - 740
  • [34] The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
    Khorjekar, Gauri
    Van Nostrand, Douglas
    Vetter, Richard
    Ringel, Matthew
    Carter, Elizabeth
    Bloom, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [35] The effect of I-131 therapy on pregnancy outcomes after thyroidectomy in patients with differentiated thyroid carcinoma: a meta-analysis
    Lijuan Zhang
    Yinqiong Huang
    Yuanyuan Zheng
    Liangchun Cai
    Junping Wen
    Gang Chen
    Endocrine, 2021, 73 : 301 - 307
  • [36] Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
    Lee, Jong Jin
    Chung, June-Key
    Kim, Sung Eun
    Kang, Won Jun
    Park, Do Joon
    Lee, Dong Soo
    Cho, Bo Youn
    Lee, Myung Chul
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (09) : 727 - 734
  • [37] The effect of I-131 therapy on pregnancy outcomes after thyroidectomy in patients with differentiated thyroid carcinoma: a meta-analysis
    Zhang, Lijuan
    Huang, Yinqiong
    Zheng, Yuanyuan
    Cai, Liangchun
    Wen, Junping
    Chen, Gang
    ENDOCRINE, 2021, 73 (02) : 301 - 307
  • [38] Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
    Jong Jin Lee
    June-Key Chung
    Sung Eun Kim
    Won Jun Kang
    Do Joon Park
    Dong Soo Lee
    Bo Youn Cho
    Myung Chul Lee
    Annals of Nuclear Medicine, 2008, 22 : 727 - 734
  • [39] Current practices in radioiodine I-131 therapy for Differentiated Thyroid Carcinoma (DTC) in Greece: Some practical and radiation protection considerations based on measurements of dose rates and I-131 retention of patients at discharge
    Samartzis, A. P.
    Mavrokefalos, P.
    Molfetas, M.
    Datseris, I.
    Alevizaki, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S341 - S341
  • [40] Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PET
    Van Nostrand, Douglas
    Khorjekar, Gauri R.
    O'Neil, Jeff
    Moreau, Shari
    Atkins, Frank B.
    Kharazi, Pejman
    Mete, Mihriye
    Chennupati, Shyam P.
    Burman, Kenneth D.
    Wartofsky, Leonard
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (03) : 359 - 362
12345